Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. CorMedix Inc shares valued at $475,200 were sold by Lefkowitz Steven W on Dec 09 ’25. At $11.88 per share, Lefkowitz Steven W sold 40,000 shares. The insider’s holdings dropped to 80,498 shares worth approximately $0.92 million following the completion of this transaction.
Also, Janet Dillione purchased 34,000 shares, netting a total of over 408,000 in proceeds.
Before that, Lefkowitz Steven W had added 40,000 shares to its account. In a trade valued at $450,400, the Director bought CorMedix Inc shares for $11.26 each.
As published in a research note from D. Boral Capital on October 20, 2025, CorMedix Inc [CRMD] has been rated up from a Hold to a Buy and the price target has been revised to $14. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. As of June 30, 2025, D. Boral Capital has decreased its “Buy” rating to a “Hold” for CRMD. Earlier on March 07, 2025, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for CRMD stock.
Analyzing CRMD Stock Performance
On last trading session, CorMedix Inc [NASDAQ: CRMD] plunged -1.29% to $11.47. The stock’s lowest price that day was $10.9, but it reached a high of $11.5395 in the same session. During the last five days, there has been a surge of approximately 11.14%. Over the course of the year, CorMedix Inc shares have jumped approximately 20.74%. Shares of the company reached a 52-week high of $17.43 on 06/23/25 and a 52-week low of $5.60 on 04/07/25.
Support And Resistance Levels for CorMedix Inc (CRMD)
According to the 24-hour chart, there is a support level at 11.07, which, if violated, would cause prices to drop to 10.66. In the upper region, resistance lies at 11.71. The next price resistance is at 11.94. RSI (Relative Strength Index) is 61.53 on the 14-day chart, showing neutral technical sentiment.
Is CorMedix Inc subject to short interest?
Stocks of CorMedix Inc saw a sharp rise in short interest on 2025-11-28 jumping by 0.48 million shares to 17.08 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 16.6 million shares. A jump of 2.82% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.55 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.55.
Which companies own the most shares of CorMedix Inc (CRMD)?
In terms of CorMedix Inc share price expectations, FactSet research, analysts set an average price target of 19.5 in the next 12 months, up nearly 67.81% from the previous closing price of $11.62. Analysts anticipate CorMedix Inc stock to reach 22 by 2025, with the lowest price target being 17. In spite of this, 2 analysts ranked CorMedix Inc stock as Buy at the end of 2025. On January 13, 2025, D. Boral Capital assigned a price target of “a Buy” to the stock and initiated coverage with a $15.
